First Tracks Biotherapeutics (TRAX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), First Tracks Biotherapeutics reported total assets of $330.55M and total liabilities of $43.05M. Shareholders' equity was $287.49M, down 26.6% from $391.60M a year earlier. Total debt stood at $14.11M against $311.64M in cash and short-term investments, a net cash position of $297.53M. That puts debt-to-equity at 0.05, compared with 0.04 a year earlier.

First Tracks Biotherapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for First Tracks Biotherapeutics, Inc. (TRAX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023
Period ending	Dec 2025	Dec 2024	Dec 2023
Current Assets
Cash and Cash Equivalents	238.20	123.08	35.97
Short-Term Investments	73.44	262.29	354.94
Cash & Short-Term Investments	311.64	385.37	390.90
Accounts Receivable	0.00	0.00	0.00
Inventory	0.00	0.00	0.00
Other Current Assets	4.76	4.56	7.65
Total Current Assets	316.40	389.93	398.56
Non-Current Assets
Property, Plant & Equipment (Net)	13.89	16.23	18.27
Long-Term Investments	0.00	35.47	27.03
Other Non-Current Assets	0.26	0.26	0.26
Total Non-Current Assets	14.15	51.96	45.55
Total Assets	330.55	441.89	444.11
Current Liabilities
Accounts Payable	3.11	3.79	2.43
Short-Term Debt	2.08	1.93	1.78
Accrued Liabilities	25.83	30.47	9.43
Other Current Liabilities	25.83	30.47	14.02
Total Current Liabilities	31.02	36.18	18.22
Non-Current Liabilities
Long-Term Debt	12.03	14.11	16.04
Other Non-Current Liabilities	0.00	0.00	0.00
Total Non-Current Liabilities	12.03	14.11	16.04
Total Liabilities	43.06	50.30	34.26
Stockholders' Equity
Common Stock	287.51	391.29	410.65
Retained Earnings	0.00	0.00	0.00
Accumulated Other Comprehensive Income	-0.02	0.31	-0.80
Shares Outstanding	-	34.75	34.75
Total Stockholders' Equity	287.49	391.60	409.85
Total Liabilities & Equity	330.55	441.89	444.11

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About First Tracks Biotherapeutics Balance Sheet

How much debt does First Tracks Biotherapeutics have?

First Tracks Biotherapeutics had total debt of $14.11M as of Dec 31, 2025, against $311.64M in cash and short-term investments. Its debt-to-equity ratio was 0.05. Total debt was $16.04M a year earlier.

What are First Tracks Biotherapeutics's total assets?

First Tracks Biotherapeutics reported total assets of $330.55M as of Dec 31, 2025, down 25.2% from $441.89M a year earlier. Total liabilities were $43.05M.

What is First Tracks Biotherapeutics's shareholders' equity?

First Tracks Biotherapeutics's shareholders' equity was $287.49M as of Dec 31, 2025.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition